Kenner, LA, United States of America

John Bland

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Bland. Retrieved from https://idiyas.com/inventor/john-bland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John Bland

Introduction

John Bland is an accomplished inventor based in Kenner, Louisiana. He has made significant contributions to the field of biotechnology, particularly in the production of chemotherapeutic agents. His work has the potential to impact cancer treatment positively.

Latest Patents

John Bland holds a patent for the "Production of taxol or taxol-like compounds in cell culture." This innovative process involves culturing the tissue of Taxus brevifolia to produce taxol, related alkaloids, and alkaloid precursors. This advancement provides a reliable supply of essential chemotherapeutic agents.

Career Highlights

Throughout his career, John has demonstrated a commitment to advancing medical science. His work has been recognized for its potential to improve cancer therapies and enhance patient outcomes. He is associated with the United States of America as Represented by the Secretary of, where he continues to contribute to research and development.

Collaborations

John has collaborated with notable colleagues, including Donna M. Gibson and Alice A. Christen. Their combined expertise has fostered a productive research environment, leading to significant advancements in their field.

Conclusion

John Bland's innovative work in the production of taxol and related compounds showcases his dedication to improving cancer treatment. His contributions to biotechnology are invaluable and highlight the importance of research in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…